Systematic review and appraisal of clinical practice guidelines on pelvic organ prolapse using the AGREE II tool

2021 ◽  
Author(s):  
Sofia Tsiapakidou ◽  
Christiana Campani Nygaard ◽  
Gabriele Falconi ◽  
Janna Pape ◽  
Cornelia Betschart ◽  
...  
Keyword(s):  
Systematic Review ◽  
Clinical Practice ◽  
Pelvic Organ Prolapse ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
Pelvic Organ ◽  
Agree Ii ◽  
Agree Ii Tool

scholarly journals Antenatal magnesium sulfate for fetal neuroprotection: a critical appraisal and systematic review of clinical practice guidelines

2019 ◽  
Vol 47 (3) ◽  
pp. 262-269 ◽  
Author(s):  
Pradeep M. Jayaram ◽  
Manoj K. Mohan ◽  
Ibrahim Farid ◽  
Stephen Lindow
Keyword(s):  
Systematic Review ◽  
Clinical Practice ◽  
Magnesium Sulfate ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
Supporting Evidence ◽  
Agree Ii ◽  
Fetal Neuroprotection ◽  
Agree Ii Tool

Abstract Background Magnesium sulfate is an accepted intervention for fetal neuroprotection. There are some perceived differences in the international recommendations on the use magnesium sulfate for fetal neuroprotection in preterm labor. Content This systematic review analyses the available clinical guidelines for the use of magnesium sulfate for fetal neuroprotection and compares the recommendations, and assesses the quality of guidelines. This provides the consensus, differences and explores the areas for future collaborative research. We searched databases of PUBMED, EMBASE, COCHRANE, Web of Science, LILACS; and included the national and the international clinical practice guidelines. We included seven guidelines out of 227 search results. We evaluated the methodological quality of guidelines using the Appraisal of Guidelines Research and Evaluation (AGREE II) tool and systematically extracted guideline characters, recommendation and supporting evidence base. Summary Five guidelines were of high quality and two were of moderate quality. One guideline achieved more than an 80% score in all the domains of AGREE II tool. All guidelines recommend use of magnesium sulfate for fetal neuroprotection. However, there are differences in other recommendations such as upper gestational age, dose, duration, repeating treatment and use of additional tocolytics. Outlook Future guidelines should include recommendations on all aspects of magnesium sulfate therapy for fetal neuroprotection. Future research and international collaboration should focus on areas where there are no international consensual recommendations.

Uterine-preserving surgeries for the repair of pelvic organ prolapse: a systematic review with meta-analysis and clinical practice guidelines

2019 ◽  
Vol 30 (4) ◽  
pp. 505-522 ◽  
Author(s):  
Kate V. Meriwether ◽  
Ethan M. Balk ◽  
Danielle D. Antosh ◽  
Cedric K. Olivera ◽  
Shunaha Kim-Fine ◽  
...  
Keyword(s):  
Systematic Review ◽  
Clinical Practice ◽  
Pelvic Organ Prolapse ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
Meta Analysis ◽  
Pelvic Organ

scholarly journals An appraisal of the Australian Resuscitation Council arrhythmia guideline

2014 ◽  
Vol 11 (6) ◽  
Author(s):  
Pieter F Fouche ◽  
Kristina Zverinova
Keyword(s):  
Clinical Practice ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
Intraclass Correlation ◽  
Rater Agreement ◽  
Agree Ii ◽  
Quality Guideline ◽  
Significant Health ◽  
Agree Ii Tool

IntroductionArrhythmias are a significant health burden in Australia, responsible for about 1% of deaths annually. The Australian Resuscitation Council (ARC) ‘Guideline 11.9 Managing Acute Dysrhythmias’ was designed to guide doctors, paramedics and nurses in the emergency management of arrhythmias. It is important to have high quality clinical practice guidelines to aid the treatment of these arrhythmias. The AGREE II tool utilised is widely used to asses clinical practice guidelines for quality. The objective of this study was to assess the quality of the ARC clinical practice guideline ‘Guideline 11.9 Managing Acute Dysrhythmias’.MethodsTwo raters assessed the six domains of quality of the ARC arrhythmia guideline using the AGREE II tool. The inter-rater agreement between the raters was measured with the intraclass correlation coefficient (ICC 2, 1).ResultsInter-rater agreement was good at 0.73 (95% CI 0.45 to 0.88). Both raters assigned the ARC guideline 11.9 Managing Acute Dysrhythmias a score of three, for a combined score of three out of a possible seven on the AGREE II rating scale.ConclusionsThe use of the ARC guideline 11.9 Managing Acute Dysrhythmias is not recommended based on this assessment with the AGREE II tool. Emergency departments and prehospital systems should consider not using this arrhythmia guideline to guide their practice, but to look elsewhere for a higher quality guideline.

Sign in / Sign up

Export Citation Format

Share Document